|
US7388079B2
(en)
*
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
US20040102369A1
(en)
*
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
|
WO2004060403A2
(en)
*
|
2003-01-06 |
2004-07-22 |
Angiochem Inc. |
Aprotinin and anglos as carriers across the blood-brain barrier
|
|
CA2519227C
(en)
|
2003-03-19 |
2013-12-03 |
Biogen Idec Ma Inc. |
Nogo receptor binding protein
|
|
EP1460088A1
(en)
|
2003-03-21 |
2004-09-22 |
Biotest AG |
Humanized anti-CD4 antibody with immunosuppressive properties
|
|
AU2003286870A1
(en)
*
|
2003-06-05 |
2005-01-04 |
Salk Institute For Biological Studies |
Targeting polypeptides to the central nervous system
|
|
US8486893B2
(en)
|
2004-06-24 |
2013-07-16 |
Biogen Idec Ma Inc. |
Treatment of conditions involving demyelination
|
|
AU2005286844A1
(en)
*
|
2004-09-17 |
2006-03-30 |
Comentis, Inc |
Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
|
|
EP1799660A2
(en)
*
|
2004-09-17 |
2007-06-27 |
Comentis, Inc. |
Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof
|
|
NZ562314A
(en)
*
|
2005-04-08 |
2010-02-26 |
Comentis Inc |
Compounds which inhibit beta-secretase activity and methods of use thereof
|
|
HRP20131066T1
(hr)
|
2005-07-08 |
2013-12-06 |
Biogen Idec Ma Inc. |
Sp35 antitijela i njihova upotreba
|
|
ES2744225T3
(es)
|
2005-07-15 |
2020-02-24 |
Angiochem Inc |
Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
|
|
US8053569B2
(en)
*
|
2005-10-07 |
2011-11-08 |
Armagen Technologies, Inc. |
Nucleic acids encoding and methods of producing fusion proteins
|
|
US8741260B2
(en)
*
|
2005-10-07 |
2014-06-03 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of GDNF to the CNS
|
|
US8124095B2
(en)
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
|
TW200736277A
(en)
*
|
2005-11-14 |
2007-10-01 |
Amgen Inc |
RANKL antibody-PTH/PTHrP chimeric molecules
|
|
CA2641070C
(en)
*
|
2006-02-06 |
2017-01-03 |
Ramot At Tel-Aviv University Ltd. |
Enzyme replacement therapy for treating lysosomal storage diseases
|
|
US8759297B2
(en)
*
|
2006-08-18 |
2014-06-24 |
Armagen Technologies, Inc. |
Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
|
|
WO2008100560A2
(en)
*
|
2007-02-14 |
2008-08-21 |
University Of Southern California |
Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
|
|
WO2008137066A1
(en)
*
|
2007-05-02 |
2008-11-13 |
The Board Of Regents Of The University Of Oklahoma |
Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
|
|
US9365634B2
(en)
*
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
US20100286145A1
(en)
*
|
2007-07-26 |
2010-11-11 |
Comentis, Inc. |
Isophthalamide derivatives inhibiting beta-secretase activity
|
|
AU2008282496B2
(en)
*
|
2007-07-27 |
2013-04-04 |
Armagen Technologies, Inc. |
Methods and compositions for increasing alpha-iduronidase activity in the CNS
|
|
JP5055432B2
(ja)
*
|
2007-09-24 |
2012-10-24 |
コメンティス，インコーポレーテッド |
治療のためのβ−セクレターゼ阻害剤としての（３−ヒドロキシ−４−アミノブタン−２−イル）−３−（２−チアゾール−２−イル−ピロリジン−１−カルボニル）ベンズアミド誘導体及び関連する化合物
|
|
EP2260057B1
(en)
|
2008-03-13 |
2016-11-23 |
Biotest AG |
Anti-CD4 antibody dosage regimen for treating autoimmune disease
|
|
RU2540013C2
(ru)
|
2008-03-13 |
2015-01-27 |
Биотест Аг |
Средство для лечения заболевания
|
|
EP2265643B1
(en)
|
2008-03-13 |
2016-10-19 |
Biotest AG |
Dosing regimen for treating psoriasis and rheumatoid arthritis
|
|
MX355683B
(es)
|
2008-04-18 |
2018-04-26 |
Angiochem Inc |
Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
|
|
EP2347004B1
(en)
*
|
2008-06-13 |
2016-08-10 |
Rappaport Family Institute for Research in the Medical Sciences |
Reagents and methods for detecting the polymorphic protein haptoglobin
|
|
CA2729961C
(en)
|
2008-07-09 |
2018-05-01 |
Biogen Idec Ma Inc. |
Li113, li62 variant co2, anti-lingo antibodies
|
|
US20100098693A1
(en)
*
|
2008-10-07 |
2010-04-22 |
Pardridge William M |
Compositions and methods for blood-brain barrier delivery of organophosphatases
|
|
WO2010043049A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
|
CA2740316A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
CA2745524C
(en)
|
2008-12-05 |
2020-06-09 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
US8853353B2
(en)
|
2008-12-17 |
2014-10-07 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
|
CA2748889A1
(en)
|
2009-03-18 |
2010-09-23 |
Armagen Technologies, Inc. |
Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
|
|
MX2011011023A
(es)
|
2009-04-20 |
2012-01-20 |
Angiochem Inc |
Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
|
|
RU2012103240A
(ru)
|
2009-07-02 |
2013-08-10 |
Ангиокем Инк. |
Мультимерные пептидные конъюгаты и их применение
|
|
SI3998078T1
(sl)
|
2009-08-28 |
2026-02-27 |
Genzyme Corporation |
Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze
|
|
EP2480888B1
(en)
|
2009-09-25 |
2016-11-30 |
XOMA Technology Ltd. |
Screening methods
|
|
US8926976B2
(en)
*
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
|
EP2485761B1
(en)
|
2009-10-09 |
2019-02-27 |
Armagen, Inc. |
Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
|
|
AU2010306940A1
(en)
|
2009-10-12 |
2012-06-07 |
Smith, Larry |
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
|
|
GB0920944D0
(en)
*
|
2009-11-30 |
2010-01-13 |
Biotest Ag |
Agents for treating disease
|
|
SI2575846T1
(sl)
|
2010-05-27 |
2015-09-30 |
Janssen Biotech, Inc. |
Peptidi, ki vežejo receptor za inzulinu podoben rastni faktor 1
|
|
AU2012346448B2
(en)
|
2011-12-02 |
2017-09-14 |
Armagen, Inc. |
Methods and compositions for increasing arylsulfatase A activity in the CNS
|
|
EP2804602B1
(en)
|
2012-01-20 |
2024-12-04 |
Del Mar Pharmaceuticals |
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma
|
|
KR102142161B1
(ko)
|
2012-05-14 |
2020-08-06 |
바이오젠 엠에이 인코포레이티드 |
운동 뉴런 관련 병태 치료용 lingo-2 길항제
|
|
JP6692293B2
(ja)
|
2013-07-22 |
2020-05-13 |
アーマジェン・インコーポレイテッドＡｒｍａｇｅｎ， Ｉｎｃ． |
Ｃｎｓにおける酵素活性を増大するための方法および組成物
|
|
AU2014368696A1
(en)
|
2013-12-20 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Humanized anti-Tau(pS422) antibodies and methods of use
|
|
EP3088518A4
(en)
|
2013-12-25 |
2017-09-20 |
JCR Pharmaceuticals Co., Ltd. |
Novel anti-transferrin receptor antibody that passes through blood-brain barrier
|
|
NZ724869A
(en)
*
|
2014-03-06 |
2022-07-01 |
Nat Res Council Canada |
Insulin-like growth factor 1 receptor -specific antibodies and uses thereof
|
|
PE20170088A1
(es)
*
|
2014-03-06 |
2017-03-09 |
Nat Res Council Canada |
Anticuerpos especificos del receptor del factor 1 de crecimiento similar a la insulina y usos de los mismos
|
|
DK3114141T3
(da)
*
|
2014-03-06 |
2020-08-10 |
Nat Res Council Canada |
Insulinlignende vækstfaktor 1-receptor-specifikke antistoffer og anvendelse deraf
|
|
AR099812A1
(es)
|
2014-03-21 |
2016-08-17 |
Abbvie Inc |
Anticuerpos y conjugados de anticuerpo y fármaco anti-egfr
|
|
SG11201608303QA
(en)
|
2014-04-04 |
2016-11-29 |
Del Mar Pharmaceuticals |
Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
|
|
AR100978A1
(es)
*
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
JP2018504400A
(ja)
|
2015-01-08 |
2018-02-15 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
Ｌｉｎｇｏ‐１拮抗薬及び脱髄障害の治療のための使用
|
|
US10538589B2
(en)
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
WO2016207245A1
(en)
|
2015-06-24 |
2016-12-29 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
|
EA039366B1
(ru)
|
2015-06-24 |
2022-01-19 |
Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. |
Антитело к рецептору трансферрина человека, проникающее через гематоэнцефалический барьер
|
|
AU2016283344B2
(en)
|
2015-06-24 |
2022-08-04 |
Jcr Pharmaceuticals Co., Ltd. |
Fusion protein containing BDNF
|
|
US11207461B2
(en)
|
2015-07-30 |
2021-12-28 |
Anoop U. R |
Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier
|
|
CA2994841A1
(en)
|
2015-08-06 |
2017-02-09 |
Xoma (Us) Llc |
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
|
|
CN107465528B
(zh)
*
|
2016-06-03 |
2022-04-15 |
中兴通讯股份有限公司 |
光分配网络odn资源信息采集方法及装置
|
|
AU2017279550A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-B7-H3 antibodies and antibody drug conjugates
|
|
WO2017214322A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
JP2019524651A
(ja)
|
2016-06-08 |
2019-09-05 |
アッヴィ・インコーポレイテッド |
抗ｃｄ９８抗体及び抗体薬物コンジュゲート
|
|
MX2018015285A
(es)
|
2016-06-08 |
2019-09-18 |
Abbvie Inc |
Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
|
|
EP3470424B1
(en)
*
|
2016-06-08 |
2025-04-23 |
Shanghai Jiao Tong University School of Medicine |
Sequence of antibody heavy chain constant region for enhancing agonist antibody activity
|
|
EP3554544A4
(en)
|
2016-12-16 |
2020-07-29 |
Bluefin Biomedicine, Inc. |
ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
|
|
CA3052936A1
(en)
|
2016-12-26 |
2018-07-05 |
Jcr Pharmaceuticals Co., Ltd. |
Fusion protein of bdnf and anti-transferrin receptor antibody
|
|
KR102497564B1
(ko)
|
2016-12-26 |
2023-02-07 |
제이씨알 파마 가부시키가이샤 |
혈액뇌관문을 통과하는 신규한 항인간 트랜스페린 수용체 항체
|
|
EP3612567B1
(en)
|
2017-04-19 |
2024-09-11 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1 antibodies and antibody drug conjugates
|
|
JOP20190248A1
(ar)
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
CA3066918A1
(en)
|
2017-06-12 |
2018-12-20 |
Bluefin Biomedicine, Inc. |
Anti-il1rap antibodies and antibody drug conjugates
|
|
WO2019023056A1
(en)
*
|
2017-07-24 |
2019-01-31 |
Janssen Biotech, Inc. |
INSULIN RECEPTOR ANTIBODIES AND USES THEREOF
|
|
CR20200129A
(es)
|
2017-10-02 |
2020-08-22 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
|
|
US20220002688A1
(en)
|
2018-12-20 |
2022-01-06 |
Armagen, Inc. |
Purification of iduronate-2-sulfatase immunoglobulin fusion protein
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US20250257338A1
(en)
|
2022-04-19 |
2025-08-14 |
Jcr Pharmaceuticals Co., Ltd. |
Glycoprotein having reduced number of mannose-6-phosphates
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
TW202530255A
(zh)
|
2023-12-15 |
2025-08-01 |
法商亞維西亞有限公司 |
抗ｉｌ－１ｒａｐ結合結構域及其抗體－藥物偶聯物
|
|
WO2025171378A1
(en)
|
2024-02-09 |
2025-08-14 |
Rezolute, Inc. |
Insulin receptor modulation for tumor associated hyperinsulinism
|